Building a diversified pipeline of differentiated multispecific therapeutics

Numab Therapeutics AG is a biotechnology company dedicated to developing innovative therapies for serious diseases.

We understand that patients may seek access to investigational therapies. While we are committed to advancing innovative therapies as quickly as possible, we do not currently offer expanded access or compassionate use programs. Participation in an approved clinical study remains the only pathway for access to our investigational therapies at this time.